Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention

Phase 4 Recruiting 1148 enrolled National Institute of Cardiovascular Diseases, Pakistan

RandomizedParallel-groupOpen-labelTreatment

Summary

Primary objective of the study is to evaluate the impact of adenosine pre-medication on incidence of slow flow/no-reflow after primary percutaneous coronary intervention.

Timeline

Start: 2025-06-01
Primary completion: 2026-05-30
Completion: 2026-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Adenosine	Small molecule	1 mg	Other
Subject	Adenosine	Small molecule	2 mg	Other

Adenosine Pre-Medication in Primary Percutaneous Coronary Intervention

Summary

Timeline

Drugs

Indications